ME/CFS Skeptic
Senior Member (Voting Rights)
Yesterday the Belgium assessment report from the ME/CFS centre in Leuven came out.
There are a lot of bad things in this report. CBT was for example said to be successful when the improvements were probably no larger than natural progression of the disease (discussion of the report here). But there were also some positive elements in it. It argues that the oxford criteria are flawed and that GET should no longer be advised. It acknowledges the problems with the PACE trial, the shift towards biomedical research in other parts of the world, that some biological anomalies have already been shown and that ME/CFS is a debilitating disease. Coming from the fiercest BPS-stronghold in Belgium I see this as a positive development.
I’ve only had a quick look at the Australian document but my impression of it was similar. Lots of frustrating elements in it, but overall the progress is obvious (discussion of the report here).
The same can be said about the 2018 report by the Dutch Health Council, which called for a shift towards more biomedical research – something that was taboo only a few years earlier.
In the US the AHRQ has updated their treatment overview, excluding research that used the Oxford criteria. The CDC has removed its GET/CBT recommendations and now says that “ME/CFS is a biological illness, not a psychologic disorder. Patients with ME/CFS are neither malingering nor seeking secondary gain. These patients have multiple pathophysiological changes that affect multiple systems.” The NIH has more than doubled its funding of ME/CFS.
In the UK NICE has overruled the advice of its experts and listened to the stakeholders: the guidelines are going to change.
It seems to me that since the 2015 IOM report and the reporting of Tuller and Coyne on the PACE-trial, there has been some progress. That may not always be visible because of the many setbacks on the way and the long road ahead. I just wanted to highlight the general trend here.
Yes, David Tovey’s recent response was disappointing but let’s not forget that Cochrane did not approve the Larun et al. resubmission and currently states that the review is substantially out of date and in need of updating. There are some bad people on the NICE committee but there are also 5 (!) lay members with full voting rights.
Perhaps it’s time to record a new Bob Dylan song. Because the times they are a changin’…
@Robert 1973
There are a lot of bad things in this report. CBT was for example said to be successful when the improvements were probably no larger than natural progression of the disease (discussion of the report here). But there were also some positive elements in it. It argues that the oxford criteria are flawed and that GET should no longer be advised. It acknowledges the problems with the PACE trial, the shift towards biomedical research in other parts of the world, that some biological anomalies have already been shown and that ME/CFS is a debilitating disease. Coming from the fiercest BPS-stronghold in Belgium I see this as a positive development.
I’ve only had a quick look at the Australian document but my impression of it was similar. Lots of frustrating elements in it, but overall the progress is obvious (discussion of the report here).
The same can be said about the 2018 report by the Dutch Health Council, which called for a shift towards more biomedical research – something that was taboo only a few years earlier.
In the US the AHRQ has updated their treatment overview, excluding research that used the Oxford criteria. The CDC has removed its GET/CBT recommendations and now says that “ME/CFS is a biological illness, not a psychologic disorder. Patients with ME/CFS are neither malingering nor seeking secondary gain. These patients have multiple pathophysiological changes that affect multiple systems.” The NIH has more than doubled its funding of ME/CFS.
In the UK NICE has overruled the advice of its experts and listened to the stakeholders: the guidelines are going to change.
It seems to me that since the 2015 IOM report and the reporting of Tuller and Coyne on the PACE-trial, there has been some progress. That may not always be visible because of the many setbacks on the way and the long road ahead. I just wanted to highlight the general trend here.
Yes, David Tovey’s recent response was disappointing but let’s not forget that Cochrane did not approve the Larun et al. resubmission and currently states that the review is substantially out of date and in need of updating. There are some bad people on the NICE committee but there are also 5 (!) lay members with full voting rights.
Perhaps it’s time to record a new Bob Dylan song. Because the times they are a changin’…
@Robert 1973
Last edited: